Define, shape and create successful global patent litigation strategies, mitigate risk and remain competitive on the global stage. This industry-driven event has been meticulously curated in collaboration with in-house counsel from pharmaceutical, biopharmaceutical, generic and biosimilar organizations. The focus? Identifying cutting-edge trends in international patent litigation that are shaping global pharma and biotech strategy. The main conference running from 29th - 30th October will examine the latest global litigation updates, risk mitigation strategies, and how to devise a cost-effective IP litigation strategy in both the US and Global market.
With an array of speakers, including Judges from the US and the UPC, law firms and a wide range of pharma and biotech companies, we are delighted to have our specialists participating in key sessions. Partner and Co-Head of Litigation in Canada, Kamleh Nicola, will sit on the industry-led panel session 'The Global Application of Skinny Labeling and Second Medical Uses', and Managing Associate (UK), Dan McGrath, will join the 'Discover Safe Harbor in the US and Bolar Exemptions in Europe' roundtable.
Join us for an in-depth exploration of critical issues and winning strategies in patent litigation. This must-attend event connects you with industry leaders and innovators actively shaping the landscape. Network with key players and gain insights to stay ahead of the curve.